Skip to main content
logo
Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
145.43
+1.50 (1.04%)
Sep 14, 2026, 1:28 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Keytruda/Keytruda Qlex Revenue
32.92B
Gardasil/Gardasil 9 Revenue
5.02B
Januvia/Janumet Revenue
2.13B
ProQuad/M-M-R II/Varivax Revenue
2.43B
Bridion Revenue
1.91B
Lynparza - Alliance Revenue
1.47B
Winrevair Revenue
1.94B
Lenvima - Alliance Revenue
1.07B
Pharmaceutical Revenue
59.56B
Animal Health Revenue
6.69B
Other Product Revenue
320.00M
Revenue (Other)
-48.89B
Revenue (Total)
66.57B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
United States Revenue
37.68B
Europe, Middle East and Africa Revenue
15.28B
Latin America Revenue
3.51B
China Revenue
1.59B
Asia Pacific (other than China and Japan) Revenue
3.07B
Japan Revenue
2.55B
Other Geographic Revenue
2.90B
Revenue (Other)
-1.00M
Revenue (Total)
66.57B

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Pharmaceutical Segment Profit
47.18B
Animal Health Segment Profit
2.26B
Other Segment Profit
-43.49B